Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-23 · accession 0001214659-24-005213 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-26 | 2024-03-23 | CPIX | Bitterman Chris T. | Vice Pres Sales, Marketing | F - Tax | $1.81 | -593 | 4,683 | -11% | -$1,073 |
| D | 2024-03-26 | 2024-03-25 | CPIX | Bitterman Chris T. | Vice Pres Sales, Marketing | A - Grant | $1.71 | +2,750 | 13.2K | +26% | +$4,702 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-23 | F | D | 593 | $1.81 | 4,683 | D | — | — | (F1) This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. |
| 2 | Derivative | Options (right to buy) | 2024-03-25 | A | A | 2,750 | $1.71 | 13,250 | D | $1.71 · 2028-03-25 to 2034-03-25 | 2,750 Common Stock |